As per Global Insight services’ assessment, about 30+ prominent pharma and biotech giants are working on 30+ drugs in the Major Depressive Disorder (MDD) – pipeline landscape globally. Major Depressive Disorder (MDD) Pipeline Insight, 2023” report by Global Insight Services provides a comprehensive analysis of the ongoing clinical development activities and growth prospect.
Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies : https://www.globalinsightservices.com/request-sample/GIS31247
Major Depressive Disorder (MDD) also known as clinical depression, is a severe mood disorder which causes persistent or extended periods of depressed or low mood, for more than 2 weeks and a loss of interest in activities thus affecting the mood and ability to function in daily life.
The most common causes of Major Depressive Disorder include genetics, trauma, isolation, significant loss, chemical and hormonal imbalances, abnormal brain chemical levels, comorbid medical illness, medicinal side effects.
Report Highlights
Global Insight Service’s, Major Depressive Disorder (MDD) – Drug Pipeline Landscape, 2023 report provides an overview of the Major Depressive Disorder (MDD) pipeline drugs. This report covers detailed insights on Major Depressive Disorder (MDD) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Major Depressive Disorder (MDD) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Key Players
• Abbvie
• Alto Neuroscience
• Alzamend Neuro
• Ancora Bio Inc
• Boehringer Ingelheim
• Cerevel Therapeutics LLC
• Chase Therapeutics Corporation
• Clexio Biosciences Ltd
• CSPC ZhongQi Pharmaceutical Technology Co Ltd
• Cybin IRL Limited
• Digestome Therapeutics
• Gate Neurosciences Inc
• Initiator Pharma
• Intra-Cellular Therapies Inc
• Johnson & Johnson
For In-Depth Competitive Analysis, Purchase this Report: https://www.globalinsightservices.com/checkout/single_user/GIS31247
Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like –
– Late-stage products (Phase III)
– Mid-stage products (Phase II)
– Early-stage product (Phase I)
– Pre-clinical and Discovery stage candidates
– Discontinued & Inactive candidates
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/